Literature DB >> 20490724

Complete regression of multiple painful bone metastases from hepatocellular carcinoma after administration of strontium-89 chloride.

Naohisa Suzawa1, Koichiro Yamakado, Haruyuki Takaki, Atsuhiro Nakatsuka, Kan Takeda.   

Abstract

A 69-year-old man received strontium-89 chloride intravenous injection to relieve uncontrollable pain from multiple hepatocellular carcinoma bone metastases. Pain was resolved 3 months later without opioid analgesics. Multiple bone metastases showed complete regression 4 months later. The patient lived for 1 year without recurrence of bone metastasis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20490724     DOI： 10.1007/s12149-010-0386-6

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  1 in total

1.  Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron).

Authors:  Joichi Heianna; Takaharu Miyauchi; Wataru Endo; Naoki Miura; Kazuyuki Terui; Syuichi Kamata; Manabu Hashimoto
Journal:  Acta Radiol Short Rep       Date:  2014-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.